Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $6.50 at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective decreased by Canaccord Genuity Group from $7.00 to $6.50 in a research note released on Thursday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.

Several other research firms have also issued reports on BIOX. Oppenheimer reduced their price target on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 28th. Lake Street Capital cut their target price on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $9.88.

Bioceres Crop Solutions Stock Performance

Bioceres Crop Solutions stock opened at $4.74 on Thursday. The company has a market cap of $297.25 million, a PE ratio of 237.12 and a beta of 0.57. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a 1 year low of $4.66 and a 1 year high of $13.80. The company’s 50-day moving average is $6.53 and its two-hundred day moving average is $7.68.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. During the same quarter in the prior year, the company earned ($0.07) earnings per share. Equities analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

Several hedge funds have recently added to or reduced their stakes in the business. Jump Financial LLC acquired a new position in Bioceres Crop Solutions in the fourth quarter valued at about $72,000. Ping Capital Management Inc. lifted its holdings in shares of Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after purchasing an additional 3,000 shares in the last quarter. Stifel Financial Corp grew its position in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the period. JPMorgan Chase & Co. increased its stake in Bioceres Crop Solutions by 17.0% during the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock worth $640,000 after purchasing an additional 15,328 shares in the last quarter. Finally, Ballast Asset Management LP raised its holdings in Bioceres Crop Solutions by 23.5% during the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock worth $2,620,000 after buying an additional 82,187 shares during the period. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.